Seto, Wai-Kay
Yuen, Man-Fung
Article History
First Online: 14 September 2016
Competing interests
: W.-K.S. is an advisory board member of Bristol-Myers Squibb and Gilead Sciences, and has received speaker fees from Bristol-Myers Squibb, Gilead Sciences and Novartis. M.-F.Y. has received speaker fees from Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline and Novartis, and has received research funding from and is an advisory board member of Biocartis, Bristol-Myers Squibb, Gilead Sciences and Novartis.